[SGMO] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
04-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 95.69%
YoY- 94.32%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 27,872 26,280 25,800 57,763 21,553 13,076 54,851 -36.34%
PBT -47,150 -45,677 -40,567 -1,271 -35,965 -42,974 4,501 -
Tax 24 262 108 237 -36 -61 179 -73.83%
NP -47,169 -45,933 -40,604 -1,550 -35,929 -42,913 4,555 -
Tax Rate - - - - - - -3.98% -
Total Cost 75,041 72,213 66,404 59,313 57,482 55,989 50,296 30.60%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -169.23 -174.78 -157.38 -2.68 -166.70 -328.18 8.30 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.33 -0.32 -0.29 -0.01 -0.26 -0.37 0.04 -
EPS Diluted -0.33 -0.32 -0.29 -0.01 -0.26 -0.37 0.04 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.